Cite Filings / CGEM / 9999999995-23-001468

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Cullinan Therapeutics, Inc. Filed 2023-05-18 Acc 9999999995-23-001468

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2024-06-04 EFFECT Notice of Effectiveness
2023-05-19 4 Chief Development Officer sold 239 shares at $8.76 ($2,094)
2023-05-19 4 Chief Medical Officer sold 394 shares at $8.76 ($3,451)
2023-05-19 4 Chief Legal Officer sold 291 shares at $8.76 ($2,549)
2023-05-19 4 Chief Financial Officer sold 399 shares at $8.76 ($3,495)
2023-05-18 EFFECT Notice of Effectiveness
2021-01-07 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…